Skip to main content


Fig. 2 | Cell Communication and Signaling

Fig. 2

From: Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma

Fig. 2

Molecular characteristics and risk score distribution in patients from CGGA dataset. a Risk score distribution among different pathologic grades. b Risk score distribution among different subtypes of patients. c Risk score distribution between MGMT promoter methylated and unmethylated patients. d-e Distribution of risk score in patients stratified by IDH status and 1p/19q status. f The ROC curve to predict the Mesenchymal subtype according to risk score

Back to article page